Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

BACKGROUND: To assess the long-term cost-effectiveness of rosuvastatin therapy compared with generic simvastatin and generic atorvastatin in reducing the incidence of cardiovascular events and mortality in a Swedish population with Framingham risk ≥20%. METHODS: A probabilistic Monte Carlo simulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Sanjay K, Jensen, Marie M, Fox, Kathleen M, Smolen, Lee, Olsson, Anders G, Paulsson, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278203/
https://www.ncbi.nlm.nih.gov/pubmed/22347800
http://dx.doi.org/10.2147/CEOR.S26621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278203/
https://www.ncbi.nlm.nih.gov/pubmed/22347800
http://dx.doi.org/10.2147/CEOR.S26621

Ejemplares similares